Immunobiology of Leprosy

  • Ward E. Bullock
Chapter
Part of the Comprehensive Immunology book series (COMIMUN, volume 8)

Abstract

Leprosy continues to be one of the major unconquered diseases of the world as witnessed by the fact that the total number of cases probably exceeds 12 million (WHO, 1977). Furthermore, this infection produces some form of physical disability in more than 25% of cases (Bechelli and Mártinéz Dominquez, 1966). Until recently, the staggering medical, social, and economic consequences of leprosy have received insufficient attention from the governments and medical research communities of more affluent nations. Within the past decade, however, the need for a global attack on leprosy has become widely recognized and tangible progress has been made.

Keywords

Migratory Inhibitory Factor Raji Cell Leprosy Patient Lepromatous Leprosy Mycobacterium Leprae 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe, M., 1970, Studies on the antigenic specificity of Mycobacterium leprae. I. Demonstration of soluble antigens in leprosy nodules by immunodiffusion, Int. J. Lepr. 38:113–125.Google Scholar
  2. Abe, M., Chinone, S., and Hirako, T., 1967, Rheumatoidfactor-like substance and antistreptolysin O antibody in leprosy serum: Significance in erythema nodosum leprosum, Int. J. Lepr. 35:336–344.Google Scholar
  3. Agnello, V., Winchester, R.J., and Kunkel, H.G., 1970, Precipitin reactions of the Clq component of complement with aggregated γ-globulin and immune complexes in gel diffusion, Immunology 19:909–919.PubMedGoogle Scholar
  4. Almeida, J.O., 1962, Serological studies on leprosy: A comparison of complement-fixation tests using antigens prepared from tubercle bacilli and beef-heart lipids with other serological reactions, Bull. WHO 26:233–240.PubMedGoogle Scholar
  5. Armstrong, J.A., and Hart, P.D., 1971, Response of cultured macrophages Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes, J. Exp. Med. 134:713–740.PubMedCrossRefGoogle Scholar
  6. Armstrong, J.A., and Hart, P.D., 1975, Phagosomelysosome interactions in cultured macrophages infected with virulent tubercle bacilli, J. Exp. Med. 142:1–16.PubMedCrossRefGoogle Scholar
  7. Azoury, F. J., and Gum, O. B., 1967, Antinuclear factors in nephrotic syndrome secondary to systemic lupus erythematosus and in leprosy, Am. J. Med. Sci. 253: 661–666.PubMedCrossRefGoogle Scholar
  8. Barbieri, T.A., and Correa, W.M., 1967, Human macrophage culture: The leprosy prognostic test (LPT) Int. J. Lepr. 35:377–381.Google Scholar
  9. Baylet, R., Gouatter, P., and Yven, J., 1973, Sur l’existence de fausses antiStreptolysines dans la lèpre, Sem. Hop. Paris 49:1093–1096.PubMedGoogle Scholar
  10. Bechelli, L.M., and Martínez Domínguez, V., 1966, The leprosy problem in the world, Bull. WHO 34:811–826.PubMedGoogle Scholar
  11. Bechelli, L.M., Kyaw Lwin, Gallego Garbajosa, P., Gyi, M.M., Uemura, K., Sundaresan, T., Tamondong, C., Matejka, M., Sansarricq, H., and Walter, J., 1974, B. C. G. vaccination of children against leprosy: Nine-year findings of the controlled WHO trial in Burma, Bull. WHO 51:93–99.PubMedGoogle Scholar
  12. Bernard, J.C., and Vazquez, C.A.J., 1973, Visceral lesions in lepromatous leprosy, Int. J. Lepr. 41:94–101.Google Scholar
  13. Blumberg, B.S., Melartin, L., Lechat, M., and Guinto, R.S., 1967, Association between lepromatous leprosy and Australia antigen, Lancet 2:173–175.PubMedCrossRefGoogle Scholar
  14. Blumberg, B.S., Melartin, L., Guinto, R., and Lechat, M., 1970, Lepromatous leprosy and Australia antigen with comments on the genetics of leprosy, J. Chron. Dis. 23:507–516.CrossRefGoogle Scholar
  15. Bonomo, L., and Dammacco, F., 1967, Characterization of thyroglobulin antibodies in leprosy, Immunology 13:565–576.PubMedGoogle Scholar
  16. Bonomo, L., and Dammacco, F., 1971, Immune complex cryoglobulinemia in lepromatous leprosy, Clin. Exp. Immunol. 9:175–181.PubMedGoogle Scholar
  17. Bonomo, L., Dammacco, F., Pinto, L., and Barbieri, G., 1963, Thyroglobulin antibodies in leprosy, Lancet 2:807–809.PubMedCrossRefGoogle Scholar
  18. Bonomo, L., Tursi, A., Trimigliozzi, G., and Dammacco, F., 1965, L. E. Cells and antinuclear factors in leprosy, Br. Med. J. 2:689–690.PubMedCrossRefGoogle Scholar
  19. Braverman, I.M., and Yen, A., 1975, Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of parents with leukocytoclastic angiitis, J. Invest. Dermatol. 64:105–112.PubMedCrossRefGoogle Scholar
  20. Brinckerhoff, W.R., and Moore, W.L., 1909, Studies upon leprosy. IV. Upon the utility of the examination of the nose and the nasal secretions for the detection of incipient cases of leprosy, Public Health Bull. 27:3–29.Google Scholar
  21. Brown, J.A.K., Stone, M.D., and Sutherland, I., 1968, B. C. G. vaccination of children against leprosy in Uganda: Results at end of second follow-up, Br. Med. J. 1:24–27.PubMedCrossRefGoogle Scholar
  22. Buck, A.A., and Hasenclever, H.F., 1963, Influence of leprosy on delayed-type skin reactions and serum agglutination titers to Candida albicans, Am. J. Hyg. 77:305–316.PubMedGoogle Scholar
  23. Bullock, W.E., 1968, Studies on immune mechanisms in leprosy. I. Depression of delayed allergic response to skin test antigens, N. Engl. J. Med. 278:298–304.CrossRefGoogle Scholar
  24. Bullock, W.E., and Fasal, P., 1971, Studies of immune mechanisms in leprosy. III. The role of cellular and humoral factors in impairment of the in vitro immune response, J. Immunol. 106:888–889.PubMedGoogle Scholar
  25. Bullock, W.E., Jr., Ho, M.F., and Chen, M.J., 1970, Studies of immune mechanisms in leprosy. II. Quantitative relationships of IgG, IgA, and IgM immunoglobulins, J. Lab. Clin. Med. 75:863–870.PubMedGoogle Scholar
  26. Bullock, W.E., Fields, J.P., and Brandriss, M., 1972, An evaluation of transfer factor therapy in lepromatous leprosy, N. Engl. J. Med. 287:1053–1059.PubMedCrossRefGoogle Scholar
  27. Bullock, W.E., Callerame, M.L., and Panner, B.J., 1974a, Immunohistologic alteration of skin and ultrastructural changes of glomerular basement membranes in leprosy, Am. J. Trop. Med. Hyg. 23:78–83.Google Scholar
  28. Bullock, W.E., Ho, M.F., and Chen, M.J., 1974b, Quantitative and qualitative studies of the local cellular exudative response in leprosy, J. Reticuloendothel. Soc. 16:259–268.PubMedGoogle Scholar
  29. Bullock, W.E., Carlson, E.M., and Gershon, R.K., 1978, The evolution of immunosuppressive cell populations in experimental mycobacterial infection, J. Immunol. 120:1709–1716.PubMedGoogle Scholar
  30. Büngeler, W., 1943, Die pathologische Anatomie der Lepra. II. Arch. Pathol. Anat. Physiol. (Virchow’s) 310:493–565.CrossRefGoogle Scholar
  31. Bush, O.B., Jr., 1958, C-reactive protein in leprosy, Int. J. Lepr. 26:123–136.PubMedGoogle Scholar
  32. Cannefax, G.R., Ross, H., and Bancroft, H., 1959, Reactivity of the RPCF test in leprosy compared with other syphilis tests, Public Health Rep. 74:45–48.PubMedCrossRefGoogle Scholar
  33. Carter, R.L., Jamison, D.G., and Vollum, R.L., 1969, Histological changes evoked in mice by Freund’s complete adjuvant, J. Pathol. 96:503–512.CrossRefGoogle Scholar
  34. Cathgart, E.S., Williams, R.C., Ross H., and Calkins, E., 1961, The relationship of the latex fixation test to the clinical and serologic manifestations of leprosy, Am. J. Med. 31:758–765.CrossRefGoogle Scholar
  35. Choyce, D. P., 1964, The eyes in leprosy, in: Leprosy in Theory and Practice, 2nd ed. (R. G. Cochrane and T. F. Davey, eds.), pp. 310–321, Williams and Wilkins, Baltimore.Google Scholar
  36. Closs, O., Mshana, R.N., and Harboe, M., 1979, Antigenic analysis of Mycobacterium leprae, Scand. J. Immunol. 9:297–302.PubMedCrossRefGoogle Scholar
  37. Cochrane, C.G., Weigle, W.O., and Dixon, F.J., 1959, The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis, J. Exp. Med. 110:481–494.PubMedCrossRefGoogle Scholar
  38. Convit, J., Pinardi, M.E., and Rojas, F.A., 1971, Some considerations regarding the immunology of leprosy, Int. J. Lepr. 39:556–564.Google Scholar
  39. Convit, J., Pinardi, M., Rodriguez-Ocha, G., Ulrich, M., Avila, J.L., and Goihman-Yahr, M., 1974, Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria, Clin. Exp. Immunol. 17:261–265.PubMedGoogle Scholar
  40. Cream, J.J., Bryceson, A.D.M., and Ryder, G., 1971, Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man, Br. J. Dermatol. 84:106–109.PubMedCrossRefGoogle Scholar
  41. Dastur, D.K., Pandya, S.S., and Antia, N.H., 1970, Nerves in the arm in leprosy. 2. Pathology, pathogenesis and clinical correlations, Int. J. Lepr. 38:30–48.Google Scholar
  42. Date, A., Thomas, A., Mathai, R., and Johny, K.V., 1977, Glomerular pathology in leprosy, Am. J. Trop. Med. Hyg. 26:266–272.PubMedGoogle Scholar
  43. Denney, O.E., 1922, Specific leprous reactions and abnormal vaccinia induced in lepers by small pox vaccination, Public Health Rep. 37:3141–3149.CrossRefGoogle Scholar
  44. Desikan, K.V., and Job, C.K., 1966, Leprous lymphadenitis: Demonstration of tuberculoid lesions, Int. J. Lepr. 34:147–154.Google Scholar
  45. Desikan, K.V., and Job, C.K., 1968, A review of postmortem findings in 37 cases of leprosy, Int. J. Lepr. 36:32–44.Google Scholar
  46. De Vries, R.R.P., Nijenhuis, L.E., Lai, A., Fat, R.F.M., and Van Rood, J.J., 1976, HLA-linked genetic control of host response to Mycobacterium leprae, Lancet 2:1328–1330.PubMedCrossRefGoogle Scholar
  47. Dharmendra and Chatterjee, K.R., 1955, Prognostic value of the lepromin test in contacts of leprosy cases, Lepr. India 27:149–152.Google Scholar
  48. Dharmendra and Lowe, J., 1942, The immunological skin tests in leprosy. II. The isolated protein antigen in relation to the classical mitsuda reaction and the early reaction to lepromin, Indian J. Med. Res. 30:9–15.Google Scholar
  49. Dierks, R.E., and Shepard, C.C., 1968, Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients, Proc. Soc. Exp. Biol. Med. 127:391–395.PubMedGoogle Scholar
  50. Doull, J.A., Guinto, R.S., Rodriguez, J.N., and Bancroft, H., 1942, The incidence of leprosy in Cordova and Talisay, Sebu, P. I., Int. J. Lepr. 10:107–131.Google Scholar
  51. Drutz, D.J., and Gutman, R.A., 1973, Renal manifestations of leprosy: Glomerulonephritis, a complication of erythema nodosum leprosum, Am. J. Trop. Med. Hyg. 22:496–502.PubMedGoogle Scholar
  52. Drutz, D.J., Chen, T.S.N., and Lu, W.H., 1972, The continuous bacteremia of lepromatous leprosy, N. Engl. J. Med. 287:159–164.PubMedCrossRefGoogle Scholar
  53. Drutz, D.J., Cline, M.J., and Levy, L., 1974, Leukocyte antimicrobial function in patients with leprosy, J. Clin. Invest. 53:380–386.PubMedCrossRefGoogle Scholar
  54. Dutta, R.N., and Saha, K., 1973, Australia antigen and lepromatous leprosy: Its incidence, persistence and relation to cell mediated immunity, Indian J. Med. Res. 61:1–8.Google Scholar
  55. Dwyer, J.M., Bullock, W.E., and Fields, J.P., 1973, Disturbance of the blood T: B lymphocyte ratio in lepromatous leprosy, N. Engl. J. Med. 228:1036–1039.CrossRefGoogle Scholar
  56. Enna, C.D., and Brand, P.W., 1970, Peripheral nerve abscess in leprosy: Report of three cases encountered in dimorphous and lepromatous leprosy, Lepr. Rev. 41:175–180.PubMedGoogle Scholar
  57. Etemadi, A. H., and Convit, J., 1974, Mycolic acids from “noncultivable” mycobacteria, Infect. Immun. 10: 236–239.PubMedGoogle Scholar
  58. Evans, M.J., Newton, H.E., and Levy, L., 1973, Early response of mouse foot pads to Mycobacterium leprae, Infect. Immun. 7:76–85.PubMedGoogle Scholar
  59. Fernandez, J.M.M., Carboni, E.A., Mercau, R.A., and Serial, A., 1962, Transformation of two borderline-lepromatous leprosy cases to tuberculoid with healing, Int. J. Lepr. 30:254–265.PubMedGoogle Scholar
  60. Fine, P.E.M., Wolf, E., Pritchard, J., Watson, B., Bradley, D.J., Festenstein, H., and Chacko, C.J.G., 1979, HLA-linked genes and leprosy: A family study in Karigiri, South India, J. Infect. Dis. 140:152–161PubMedCrossRefGoogle Scholar
  61. Fisher, C.A., and Barksdale, L., 1973, Cytochemical reactions of human leprosy bacilli and mycobacteria: Ultrastructural implications, J. Bacteriol. 113:1389–1399.PubMedGoogle Scholar
  62. Fite, G.L., 1941, Vascular lesions of leprosy, Int. J. Lepr. 9:193–202.Google Scholar
  63. Fliess, E.L., Ruibal-Ares, B., and Braun, A., 1975, Serum factors affecting the cell migration inhibition response to lepromin, Int. J. Lepr. 43:320–325.Google Scholar
  64. Francis, T.I., and Smith, J.A., 1972, Australia [Au(1)] antigen in Nigerian patients with leprosy, Int. J. Lepr. 40:68–72.Google Scholar
  65. Gajl-Peczalska, K.J., Soo Duk Lim, Jacobson, R.R., and Good, R.A., 1973. B lymphocytes in lepromatous leprosy, N. Engl. J. Med. 288:1033–1035.PubMedCrossRefGoogle Scholar
  66. Garner, M.F., Backhouse, J.L., Collins, C.A., and Roeder, P.J., 1969, Serological tests for treponemal infection in leprosy patients, Br. J. Vener. Dis. 45:19–22.PubMedGoogle Scholar
  67. Gelber, R.H., Drutz, D.J., Epstein, W.V., and Fasal, P., 1974, Clinical correlates of Clq-precipitating substances in the sera of patients with leprosy, Am. J. Trop. Med. Hyg. 23:471–475.PubMedGoogle Scholar
  68. Godai, T., and Negassi, K., 1973, Subclinical infections in leprosy, Br. Med. J. 2:557–559.CrossRefGoogle Scholar
  69. Godai, T., and Rees, R.J.W., 1970, Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy, Int. J. Lepr. 38:439–442.Google Scholar
  70. Godai, T., Myklestad, B., Samuel, D.R., and Myrvang, B., 1971, Characterization of the cellular immune defect in lepromatous leprosy: A specific lack of circulating Mycobacterium leprae-reactive lymphocytes, Clin. Exp. Immunol. 9:821–831.Google Scholar
  71. Godal, T. Myrvang, B., Froland, S.S., Shao, J., and Melaku, G., 1972, Evidence that the mechanism of immunological tolerance (“central failure”) is operative in the lack of host resistance in lepromatous leprosy, Scand. J. Immunol. 1:311–321.PubMedCrossRefGoogle Scholar
  72. Goihman-Yahr, M., Rodriguez-Ochoa, G., Aranzazu, N., and Convit, J., 1975, Polymorphonuclear activation in leprosy, Clin. Exp. Immunol. 20:257–264.PubMedGoogle Scholar
  73. Gordon, J., and White, R.G., 1971, Surface peptido-glycolipid filaments on Mycobacterium leprae, Clin. Exp. Immunol. 9:539–547.PubMedGoogle Scholar
  74. Guinto, R.S., and Mabalay, M.A., 1962, Note on tuberculin reaction in leprosy, Int. J. Lepr. 30:278–283.PubMedGoogle Scholar
  75. Han, S.H., Weiser, R.S., and Kau, S.T., 1971a, Prolonged survival of skin allografts in leprosy patients, Int. J. Lepr. 39:1–6.Google Scholar
  76. Han, S.H., Weiser, R.S., Tseng, J.J., and Kau, S.T., 1971b, Lymphocyte transfer reactions in leprosy patients, Int. J. Lepr. 39:715–718.Google Scholar
  77. Han, S.H., Weiser, R.S., Wang, J.J., Tsai, L.C., and Lin, P.R., 1974, The behavior of leprous lymphocytes and macrophages in the macrophage migration-inhibition test, Int. J. Lepr. 42:186–192.Google Scholar
  78. Hansen, G.A., 1874, Causes of leprosy, Nor. Mag. Laegevidensk. 4:76–79.Google Scholar
  79. Harboe, M., Closs, O., Bjune G., Kronvall, G., and Axelsen, N.H., 1978, Mycobacterium leprae specific antibodies detected by radioimmunoassay, Scand. J. Immunol. 7:111–120.PubMedCrossRefGoogle Scholar
  80. Hastings, R.C., and Job, C.J., 1978, Reversal reaction in lepromatous leprosy following transfer factor therapy, Am. J. Trop. Med. Hyg. 27:995–1004.PubMedGoogle Scholar
  81. Hastings, R.C., Morales, M.J., Shannon, E.J., and Jacobson, R.R., 1976, Preliminary results on the safety and efficacy of transfer factor in leprosy, Int. J. Lepr. 44:275.Google Scholar
  82. Hokama, Y., Su, D.W.P., Skinsenes, O.K., Kim, R., Kimura, L., and Yanagihara, E., 1974, Effect of C-reactive protein, PHA, PWM and choline phosphate in 3H-thymidine uptake of leukocytes of leprosy patients and normal individuals, Int. J. Lepr. 42:19–27.Google Scholar
  83. Imaeda, T., 1965, Electron microscopy: Approach to leprosy research, Int. J. Lepr. 33:669–683.PubMedGoogle Scholar
  84. Iveson, J.M.I., McDougall, A.C., Leathern, A.J., and Harris, H.J., 1975, Lepromatous leprosy presenting with polarthritis, myositis and immune-complex glomerulonephritis, Br. Med. J. 2:619–621.CrossRefGoogle Scholar
  85. Jha, P., Balakrishnan, K., Talwar, G.P., and Bhutani, L.K., 1971, Status of humoral immune responses in leprosy, Int. J. Lepr. 39:14–19.Google Scholar
  86. Job, C.K., 1970, Lysosomal activity of macrophages in leprosy, Arch. Pathol. 90:547–552.PubMedGoogle Scholar
  87. Job, C.K., 1971, Pathology of peripheral nerve lesions in lepromatous leprosy — A light and electron microscopic study, Int. J. Lepr. 39:251–268.Google Scholar
  88. Job, C.K., Gude, S., and Macaden, V.P., 1964, Erythema nodosum leprosum, Int. J. Lepr. 32:177–184.PubMedGoogle Scholar
  89. Johny, K.V., Karat, A.B.A., Rao, P.S.S., and Date, A., 1975, Glomerulonephritis in leprosy — A percutaneous renal biopsy study, Lepr. Rev. 46:29–37.PubMedGoogle Scholar
  90. Karat, A.B.A., Karat, S., Job, C.K., and Furness, M.A., 1967, Acute exudative arthritis in leprosy: Rheumatoid-arthritis-like syndrome in association with erythema nodosum leprosum, Br. Med. J. 3:770–772.PubMedCrossRefGoogle Scholar
  91. Karat, A.B.A., Karat, S., Job, C., and Sudarsanam, D., 1968, Acute necrotizing lepromatous lymphadenitis: An erythema-nodosum-leprosum like reaction in lymph nodes, Br. Med. J. 2:223–224.CrossRefGoogle Scholar
  92. Karat, A.B.A., Job, C.K., and Rao, R.S.S., 1971, Liver in leprosy: Histological and biochemical findings, Br. Med. J. 1:307–310.PubMedCrossRefGoogle Scholar
  93. Katz, D. H., 1972, The allogeneic effect on immune responses: Model for regulatory influence of T lymphocytes on the immune system, Transplant. Rev. 12: 141–179.PubMedGoogle Scholar
  94. Katz, S.I., DeBetz, B.H., and Zaias, N., 1971, Production of macrophage inhibitory factor by patients with leprosy, Arch. Dermatol. 103:358–361.PubMedCrossRefGoogle Scholar
  95. Kent, J.F., Otero, A.B., and Harrigan, R.E., 1957, Relative specificity of serologic tests for syphilis in Mycobacterium leprae infections, Am. J. Clin. Pathol. 27:539–545.PubMedGoogle Scholar
  96. Kirchheimer, W.F., and Sanchez, R.M., 1976, Quantitative aspects of leprosy in armadillos, Int. J. Lepr. 44:84–87.Google Scholar
  97. Kraus, S.J., Haserick, J.R., Logan, L.C., and Bullard, J.C., 1971, Atypical fluorescence in the fluorescent treponemal antibody absorption (FIA-ABS) test related to deoxyribonucleic acid (DNA) antibodies, J. Immunol. 106:1665–1669.PubMedGoogle Scholar
  98. Kress, Y., Bloom, B.R., Wittner, M., Rowen, A., and Tanowitz, H., 1975, Resistance of Trypansoma cruzi to killing by macrophages, Nature (London) 257:394–396.CrossRefGoogle Scholar
  99. Kronvall, G., Husby, G., Samuel, D., Bjune, G., and Wheate, H., 1975, Amyloid-related serum component (protein ASC) in leprosy patients, Infect. Immun. 11:969–972.PubMedGoogle Scholar
  100. Kuper, S. W. A., 1958, Histological changes in the lepromin reaction induced by BCG in leprosy patients, in: Transactions of Chest and Heart Disease Conference, p. 67-71, London.Google Scholar
  101. Lara, C.B., and Nolasco, J.O., 1956, Self-healing or abortive and residual forms of childhood leprosy and their probable significance, Int. J. Lepr. 24:245–263.PubMedGoogle Scholar
  102. Lawrence, H.S., Al-Askari, S., David, J., Franklin, E.C, and Zweiman, B., 1963, Tranfer of immunological information in humans with dialysates of leukocyte extracts, Tr. Assoc. Am. Physicians 76:84–91.Google Scholar
  103. Levin, M., Pras, M., and Franklin, E.C., 1973, Immunologic studies of the major non-immunoglobulin protein of amyloid, J. Exp. Med. 138:373–380.PubMedCrossRefGoogle Scholar
  104. Levine, M., 1951, Hemagglutination of tuberculin sensitized sheep cells in Hansen’s disease, Proc. Soc. Exp. Biol. Med. 76:111–173.Google Scholar
  105. Levy, L., Fasal, P., and Murray, L.P., 1969, Morphology of Mycobacterium leprae in tissue sections, Arch. Dermatol. 100:618–620.PubMedCrossRefGoogle Scholar
  106. Lim, S.D., and Fusaro, R.M., 1968, Leprosy. IV. Quantitation of immune globulins (IgG, IgA, and IgM) in leprosy sera, Int. J. Lepr. 36:144–153.Google Scholar
  107. Lim, S.D., Fusaro, R., and Good, R.A., 1972, Leprosy. VI. The treatment of leprosy patients with intravenous infusions of leukocytes from normal persons, Clin. Immunol. Immunopathol. 1:122–139.CrossRefGoogle Scholar
  108. Lim, S.D., Kim, W.S., Kim, L.S., Good, R.A., and Park, B.H., 1974a, NBT responses of neutrophils and monocytes in leprosy, Int. J. Lepr. 42:150–153.Google Scholar
  109. Lim, S.D., Kiszkiss, D.F., Jacobson, R.R., Choi, Y.S., and Good, R.A., 1974b, Thymus-dependent lymphocytes of peripheral blood in leprosy patients, Infect. Immun. 9:394–399.PubMedGoogle Scholar
  110. Lim, S.D., Jacobson, R.R., Park, B.H., and Good, R.A., 1975, Leprosy. XII. Quantitative analysis of thymus-derived lymphocyte response to phytohaemagglutinin in leprosy, Int. J. Lepr. 43:95–100.Google Scholar
  111. Mabalay, M.D., Helwig, E.B., Tolentino, J.G., and Binford, C.H., 1965, The histopathology and histochemistry of erythema nodosum leprosum, Int. J. Lepr. 33:28–49.PubMedGoogle Scholar
  112. McAdam, K.P.W.J., Anders, R.F., Smith, S.R., Russell, D.A., and Price, M.A., 1975, Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leukocytosis in leprosy, Lancet 2:572–575.PubMedCrossRefGoogle Scholar
  113. Maderazo, E.G., Ward, P.A., Woronick, C.L., Kubik, J., and DeGraff, A.C., Jr., 1976, Leukotactic dysfunction in sarcoidosis, Ann. Intern. Med. 84:414–419.PubMedGoogle Scholar
  114. Matthews, L.J., and Trautman, J.F., 1965, Clinical and serological profiles in leprosy, Lancet 2:915–918.PubMedCrossRefGoogle Scholar
  115. Mehra, V., and Bloom, B.R., 1979, The induction of cellmediated immunity to human M. leprae in the guinea pig, Infect. Immun. 23:787–794.PubMedGoogle Scholar
  116. Mehra, V.L., Talwar, G.P., Balakrishnan, K., and Bhutani, L.K., 1972, Influence of chemotherapy and serum factors on the mitogenic response of peripheral leukocytes of leprosy patients to phytohaemagglutinin, Clin. Exp. Immunol. 12:205–213.PubMedGoogle Scholar
  117. Mendes, E., Raphael, A., Mota, N.G.S., and Mendes, N.F., 1974a, Cell-mediated immunity in leprosy and transfer of delayed hypersensitivity reactions, J. Allergy Clin. Immunol. 53:223–229.PubMedCrossRefGoogle Scholar
  118. Mendes, N.F., Kopersztych, S., and Mota, N.G.S., 1974b, T and B lymphocytes in patients with lepromatous leprosy, Clin. Exp. Immunol. 16:23–30.PubMedGoogle Scholar
  119. Mitsuda, K., and Ogawa, M.A., 1937, Study of one hundred and fifty autopsies on cases of leprosy, Int. J. Lepr. 5:53–60.Google Scholar
  120. Moran, C.J., Ryder, G., Turk, J.L., and Waters, M.F.R., 1972, Evidence for circulating immune complexes in lepromatous leprosy, Lancet 2:572–573.PubMedCrossRefGoogle Scholar
  121. Mortensen, R.F., Osmand, A.P., and Gewurz, H., 1975, Effects of C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions, J. Exp. Med. 141:821–839.PubMedGoogle Scholar
  122. Mortensen, R.F., Braun, D., and Gewurz, H., 1977, Effects of C-reactive protein on the lymphoid system. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production, Cell. Immunol. 28:59–68.PubMedCrossRefGoogle Scholar
  123. Moschella, S.L., 1967, The lepra reaction with necrotizing skin lesions, Arch. Dermatol. 95:565–575.PubMedCrossRefGoogle Scholar
  124. Mostert, H.V.R., 1936, Bacillaemia in leprosy, Lepr. Rev. 7:6–10.Google Scholar
  125. Myrvang, B., 1974, Immune responsiveness to Mycobacterium leprae of healthy humans: Application of the leukocyte migration inhibition test, Acta Pathol. Microbiol. Scand. Sect. B 82:707–714.Google Scholar
  126. Myrvang, B., Godai, T., Ridley, D.S., Froland, S.S., and Song, Y.K., 1973, Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy, Clin. Exp. Immunol. 14:541–553.PubMedGoogle Scholar
  127. Mryvang, B., Feek, C.M., and Godai, T., 1974, Antimycobacterial antibodies in sera from patients throughout clinico-pathological disease spectrum of leprosy, Acta Pathol. Microbiol. Scand. 82B:701–706.Google Scholar
  128. Nakamura, M., 1972, Multiplication of M. lepraemurium in cell-free medium containing α-ketoglutaric acid and cytochrome c, J. Gen. Microbiol. 73:193–195.PubMedGoogle Scholar
  129. Narayanan, E., Shankara Manja, K., Bedi, B.M.S., Kirchheimer, W.F., and Balasurbrahmanyan, M., 1972, Arthropod feeding experiments in lepromatous leprosy, Lepr. Rev. 43:188–193.PubMedGoogle Scholar
  130. Nath, I., Curtis, J., Bhutani, L.K., and Talwar, G.P., 1974, Reduction of a subpopulation ot T lymphocytes in lepromatous leprosy, Clin. Exp. Immunol. 18:81–87.Google Scholar
  131. Nath, I., Curtiss, J., Sharma, A.K., and Talwar, G.P., 1977, Circulating T-cell numbers and their mitogenic potential in leprosy — Correlation with mycobacterial load, Clin. Exp. Immunol. 29:393–400.PubMedGoogle Scholar
  132. Navalkar, R.G., Norlin, M., and Ouchterlony, O., 1964, Characterization of leprosy sera with various mycobacterial antigens using double diffusion-in-gel analysis. II, Int. Arch. Allergy 8:250–260.Google Scholar
  133. Nelson, D.S., Nelson, M., Thurston, J.M., Waters, M.F.R., and Pearson, J.M.H., 1971, Phytohaemagglutinin-induced lymphocyte transformation in leprosy, Clin. Exp. Immunol. 9:33–43.PubMedGoogle Scholar
  134. Nelson, D.S., Penrose, J.M., Waters, M.F.R., Pearson, J.M.H., and Nelson, M., 1975, Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions, Clin. Exp. Immunol. 22:388–392.Google Scholar
  135. Nelson, R.A., Jr., 1952, Changing concepts in the serodiagnosis of syphilis: Specific treponemal antibody versus Wasserman Reagin, Br. J. Vener. Dis. 28:160–168.PubMedGoogle Scholar
  136. Noordeen, S.K., 1971, Relapse in lepromatous leprosy, Lepr. Rev. 42:43–48.PubMedGoogle Scholar
  137. Okada, S., 1954, Studies on tuberculoid visceral leprosy: Tuberculoid granuloma in the liver, revealed by puncture biopsy, Int. J. Lepr. 22:41–46.PubMedGoogle Scholar
  138. Oleinick, A., 1969, Altered immunity and cancer risk: A review of the problem and analysis of the cancer mortality experience of leprosy patients, J. Natl. Cancer Inst. 43:775–781.PubMedGoogle Scholar
  139. Papageorgiou, P.S., Sorokin, C.F., Kouzoutzakoglou, K., Bonforte, R.J., Workman, P.L., and Glade, P.R., 1973, Host responses to Epstein-Barr virus and cytomegolovirus infection in leprosy, Infec. Immun. 7:620–624.Google Scholar
  140. Paradisi, E.R., de Bonaparte, Y.P., and Morgenfeld, M.C., 1969, Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors, N. Engl. J. Med. 280:859–861.CrossRefGoogle Scholar
  141. Paul, R.C., Stanford, J.L., and Carswell, J.W., 1975, Multiple skin testing in leprosy, J. Hyg. 75:57–68.CrossRefGoogle Scholar
  142. Pearson, J.M.H., and Ross, W.F., 1975, Nerve involvement in leprosy — Pathology, differential diagnosis and principles of management, Lepr. Rev. 46:199–212.PubMedGoogle Scholar
  143. Pearson, J.M.H., Rees, R.J.W., and Waters, M.F.R., 1975, Sulphone resistance in leprosy: A review of one hundred proven clinical cases, Lancet 2:69–72.PubMedCrossRefGoogle Scholar
  144. Pearson, J.F.H., Cap, J.A., Haile, G.S., and Rees, R.J.W., 1977, Dapsone-resistant leprosy and its implications for leprosy control programs, Lepr. Rev. 48:83–94.PubMedGoogle Scholar
  145. Pedley, J.C., 1968, The presence of M. leprae in the lumina of the female mammary gland, Lepr. Rev. 39:201–202.PubMedGoogle Scholar
  146. Pedley, J.C., 1970, Summary of results of a search of the skin surface for Mycobacterium leprae, Lepr. Rev. 41:167–168.PubMedGoogle Scholar
  147. Petchclai, B., Chutanondh, R., Prasongsom, S., Hiranras, S., and Ramasoota, T., 1973, Complement profile in leprosy, Am. J. Trop. Med. Hyg. 22:761–764.PubMedGoogle Scholar
  148. Petit, J.H.S., and Waters, M.F.R., 1967, The etiology of erythema nodosum leprosum, Int. J. Lepr. 35:1–10.Google Scholar
  149. Prabhakaran, K., Kirchheimer, W.F., and Harris, E.B., 1968, Oxidation of phenolic compounds by Mycobacterium leprae and inhibition of phenolase by substrate analogues and copper chelators, J. Bacteriol. 95:2051–2053.PubMedGoogle Scholar
  150. Purtilo, D.T., and Pangi, C., 1975, Incidence of cancer in patients with leprosy, Cancer 35:1259–1261.PubMedCrossRefGoogle Scholar
  151. Quismorio, F.P., Rea, T.H., Levan, N.E., and Friou, G.J., 1975, Immunoglobulin deposits in lepromatous leprosy skin, Arch. Dermatol. 111:331–334.PubMedCrossRefGoogle Scholar
  152. Ramanujam, K., and Ramu, G., 1966, Small pox vaccination and acute exacerbation of leprosy, Lepr. India 38:3–9.Google Scholar
  153. Rea, T.H., Quismorio, F.P., Harding, B., Nies, K.M., Di Saia, P.J., Levan, N.E., and Friou, G.J., 1976a, Immunologic responses in patients with lepromatous leprosy, Arch. Dermatol. 112:791–800.PubMedCrossRefGoogle Scholar
  154. Rea, T.H., Levan, N.E., and Terasaki, P., 1976b, Histocompatibility antigens in patients with leprosy, J. Infect. Dis. 134:615–618.PubMedCrossRefGoogle Scholar
  155. Rees, R.J.W., 1964, The significance of the lepromin reaction in man, Prog. Allergy 8:224–258.Google Scholar
  156. Rees, R. J. W., 1975, in: Proceedings of the U.S.-Japan Cooperative Medical Science Program, Workshop on Chemotherapy, Bethesda, Md., October 26, p. 3.Google Scholar
  157. Rees, R. J. W., 1976, personal communication.Google Scholar
  158. Rees, R.J.W., and Meade, T.W., 1974, Comparison of the modes of spread and the incidence of tuberculosis and leprosy, Lancet 1:47–48.PubMedCrossRefGoogle Scholar
  159. Rees, R.J.W., and Valentine, R.C., 1962, The appearance of dead leprosy bacilli by light and electron microscopy, Int. J. Lepr. 30:1–9.PubMedGoogle Scholar
  160. Rees, R. J. W., Chatterjee, K. R., Pepys, J., and Tee, R. D., 1965, Some immunologic aspects of leprosy, Am. Rev. Resp. Dis. 92(2):139–149.PubMedGoogle Scholar
  161. Rich, A.R., 1951, The Pathogenesis of Tuberculosis, 2nd ed., pp. 797, 827, Thomas, Springfield, Ill.Google Scholar
  162. Ridley, D.S., 1969, Reactions in leprosy, Lepr. Rev. 40:77–81.PubMedGoogle Scholar
  163. Ridley, D.S., 1972, The pathogenesis of the early skin lesion in leprosy, J. Pathol. 111:191–206.CrossRefGoogle Scholar
  164. Ridley, D.S., 1974, Histological classification and the immunological spectrum of leprosy, Bull. WHO 51:451–465.PubMedGoogle Scholar
  165. Ridley, D.S., and Jopling, W.H., 1966, Classification of leprosy according to immunity, Int. J. Lepr. 34:255–273.Google Scholar
  166. Rojas-Espinosa, O., Mendez-Navarrete, I., and Estrada-Parra, S., 1972, Presence of Clq-reactive immune complexes in patients with leprosy, Clin. Exp. Immunol. 12:215–223.PubMedGoogle Scholar
  167. Ross, H., 1954, The results of a modified Middlebrook Dubos hemagglutination test in leprosy, Int. J. Lepr. 22:174–180.PubMedGoogle Scholar
  168. Ross, H., 1960, Immunochemical determination of orosomucoid in the blood serum of leprosy patients, Int. J. Lepr. 28:267–270.PubMedGoogle Scholar
  169. Ruge, H.G.C., 1967, Treponemal immobilization tests in leprosy, Br. J. Vener. Dis. 43:191–196.PubMedGoogle Scholar
  170. Saha, K., Mittal, M.M., and Ray, L.S.N., 1973, Consequences of small pox vaccination in leprosy patients, Infec. Immun. 8:301–308.Google Scholar
  171. Saitz, E.W., Dierks, R.E., and Shepard, C.C., 1968, Complement and the second component of complement in leprosy, Int. J. Lepr. 36:400–404.Google Scholar
  172. Salzano, F.M., 1967, Blood groups and leprosy, J. Med. Genet. 4:102–106.PubMedCrossRefGoogle Scholar
  173. Sato, S.; and Makoto, I., 1968, The surface structure of M. leprae, Int. J. Lepr. 36:303–308.Google Scholar
  174. Satyanarayana, B.V., Raju, P.S., Raja Kumari, K., and Reddy, C.R.R.M., 1972, Amyloidosis in leprosy, Int. J. Lepr. 40:278–280.Google Scholar
  175. Schujman, S., 1956, Subsequent evolution of the induced Mitsuda reaction in clinically and bacteriologically negative lepromatous cases, Int. J. Lepr. 24:51–56.PubMedGoogle Scholar
  176. Scotti, A.T., Mackey, D.M., and Trautman, J.R., 1970, Syphilis and biologic false positive reactors among leprosy patients, Arch. Dermatol. 101:328–330.PubMedCrossRefGoogle Scholar
  177. Sharma, K.D., and Shrivastav, J.B., 1958, Lymph nodes in leprosy, Int. J. Lepr. 26:41–50.PubMedGoogle Scholar
  178. Sheagren, J.N., Block, J.B., Trautman, J.R., and Wolff, S.M., 1969, Immunologie reactivity in patients with leprosy, Ann. Intern. Med. 70:295–302.PubMedGoogle Scholar
  179. Shepard, C.C., 1962, The nasal excretion of Mycobacterium laprae in leprosy, Int. J. Lepr. 30:10–18.PubMedGoogle Scholar
  180. Shepard, C.C., and McRae, D.H., 1965, Mycobacterium leprae in mice: Minimal infectious dose, relationship between staining quality and infectivity, and effect of cortisone, J. Bacteriol. 89:365–372.PubMedGoogle Scholar
  181. Shepard, C.C., and McRae, D., 1971, Hereditary characteristic that varies among isolates of Mycobacterium leprae, Infec. Immun. 3:121–126.Google Scholar
  182. Sher, R., Holm, G., Kok, S.H., Koornhof, H.J., and Glover, A., 1976, T and CR and lymphocyte profile in leprosy and the effect of treatment, Infec. Immun. 13:31–35.Google Scholar
  183. Silva, C., Lima, A.O., Andrade, L.M.C., and Mattos, O., 1973, Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors, Clin. Exp. Immunol. 15:87–92.PubMedGoogle Scholar
  184. Skinsnes, 1978, Int. J. Lepr. 46:394–413Google Scholar
  185. Sobel, A.T., Bokish, V.A., and Müller-Eberhard, H.J., 1975, Clq deviation test for the detection of immune complexes, aggregates of IgG and bacterial products in human sera, J. Exp. Med. 142:139–151.PubMedCrossRefGoogle Scholar
  186. Solis, F., and Wade, H.W., 1925, Bacteriologie findings in children of lepers with special reference to nasal lesions, J. Philipp. Isl. Med. Assoc. 5:365–369.Google Scholar
  187. Stanford, J.L., Rook, G.A.W., Convit, J., Godai, T., Kronvall, G., Rees, R.J.W., and Walsh, G.P., 1975, Preliminary taxonomic studies on the leprosy bacillus, Br. J. Exp. Pathol. 56:579–585.PubMedGoogle Scholar
  188. Stewart-Tull, D.E.S., and Davies, M., 1972, Adjuvant activity of Mycobacterium leprae, Infec. Immun. 6:909–912.Google Scholar
  189. Tajiri, I., 1955, The “acute infiltration” reaction of lepromatous leprosy, Int. J. Lepr. 23:370–384.PubMedGoogle Scholar
  190. Theofilopoulos, A.N., Wilson, C.B., and Dixon, F.J., 1976, The Raji cell radioimmune assay for detecting immune complexes in human sera, J. Clin. Invest. 57:169–182.PubMedCrossRefGoogle Scholar
  191. Tin Shwe, 1972a, Antistreptolysin O titer in leprosy, Int. J. Lepr. 40:389–391.Google Scholar
  192. Tin Shwe, 1972b, Immune complexes in glomeruli of patients with leprosy, Lepr. Rev. 52:282–289.Google Scholar
  193. Tin Shwe, and Petty, R.E., 1971, Activation of complement (C3) in patients with leprosy, Lepr. Rev. 42:277–281.Google Scholar
  194. Tung, K.S.K., Kim, B., Bjorvatn, B., Kronvall, G., McLaren, L.C., and Williams, R.C., Jr., 1977, Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy, J. Infect. Dis. 136:216–221.PubMedCrossRefGoogle Scholar
  195. Turk, J.L., and Waters, M.F.R., 1969, Cell-mediated immunity in patients with leprosy, Lancet 2:243–246.PubMedCrossRefGoogle Scholar
  196. Turk, J.L., and Waters, M.F.R., 1971, Immunological significance of changes in lymph nodes across the leprosy spectrum, Clin. Exp. Immunol. 8:363–376.PubMedGoogle Scholar
  197. U.S. Leprosy Panel, 1975, Rifampin therapy of lepromatous leprosy, Am. J. Trop. Med. Hyg. 24:475–484.Google Scholar
  198. Waldman, T.A., and Broder, S., 1977, Suppressor cells in the regulation of the immune response, Prog. Clin. Immunol. 3:155–199.Google Scholar
  199. Waldorf, D.S., Sheagren, J.N., Trautman, J.R., and Block, J.B., 1966, Impaired delayed hypersensitivity in patients with lepromatous leprosy, Lancet 2:773–775.PubMedCrossRefGoogle Scholar
  200. Wall, J.R., and Wright, D.J.M., 1974, Antibodies against testicular germinal cells in lepromatous leprosy, Clin. Exp. Immunol. 17:51–59.PubMedGoogle Scholar
  201. Ward, P.A., and Berenberg, J.L., 1974, Defective regulation of inflammatory mediators in Hodgkin’s disease: Supernormal levels of chemotactic factor inactivator, N. Engl. J. Med. 290:76–80.PubMedCrossRefGoogle Scholar
  202. Ward, P.A., Goralnick, S.J., and Bullock, W.E., 1976, Defective leukotaxis in patients with lepromatous leprosy, J. Lab. Clin. Med. 87:1025–1032.PubMedGoogle Scholar
  203. Waters, M.F.R., and Helmy, H.S., 1974, The relationship of Dapsone (DDS) therapy to erythema nodosum leprosum, Lepr. Rev. 45:299–307.PubMedGoogle Scholar
  204. Waters, M.F.R., Rees, R.J.W., McDougall, A.C., and Wedell, A.G.M., 1974, Ten years of dapsone in lepromatous leprosy: Clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli, Lepr. Rev. 45:288–298.PubMedGoogle Scholar
  205. Weddell, A. G. M., Jamison, D. G., and Palmer, E., 1964, Recent investigations into the sensory and neurohistological changes in leprosy, in: Leprosy in Theory and Practice (R. G. Cochrane and T. F. Davey, eds.), pp. 205–220, Williams and Wilkins, Baltimore.Google Scholar
  206. Wemambu, S.M.G., Turk, J.L., Waters, M.F.R., and Rees, R.J.W., 1969, Erythema nodosum leprosum: A clinical manifestation of the Arthus phenomenon, Lancet 2:933–935.PubMedCrossRefGoogle Scholar
  207. White, R.G., Jolies, P., Samour, D., and Lederer, R., 1964, Correlation of adjuvant activity and chemical structure of wax D fractions of mycobacteria, Immunology 7:158–171.PubMedGoogle Scholar
  208. Williams, R.C., Jr., Cathcart, E.S., Calkins, E., Fite, G.L., Tubio, J.B., and Cohen, A.S., 1965, Secondary amyloidosis in lepromatous leprosy: Possible relationships of diet and environment, Ann. Intern. Med. 62:1000–1007.PubMedGoogle Scholar
  209. Wisniewski, H.M., and Bloom, B.R., 1975, Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction, J. Exp. Med. 141:346–359.PubMedCrossRefGoogle Scholar
  210. WHO Memorandum, 1973, Immunological problems in leprosy research. 2, Bull. WHO 48:483–491.Google Scholar
  211. WHO, 1977, Technical Report Series No. 607, World Health Organization, Geneva, Switzerland.Google Scholar
  212. Wright, D.J.M., 1973, The significance of the fluorescent treponemal antibody (FTA-ABS) test in collagen disorders and leprosy, J. Clin. Pathol. 26:968–972.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • Ward E. Bullock
    • 1
  1. 1.Department of MedicineUniversity of Kentucky Medical CenterLexingtonUSA

Personalised recommendations